Product Description: Zelasudil is a Rho-associated (ROCK) kinase inhibitor. Zelasudil has a ROCK2 binding affinity[1][2].
Applications: Cancer-Kinase/protease
Formula: C22H21F2N7O
References: [1]WHO Drug Information-World Health Organization (WHO)./[2]Lee E, et al. Selective ROCK2 inhibition for treatment of edema and associated conditions: World Intellectual Property Organization, WO2022169946. 2022-08-11.